Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Sunaga

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Anticancer Research|March 1, 1991
Inhibition by 1-(2-tetrahydrofuryl)-5-fluorouracil in combination with uracil of hepatocarcinogenesis induced by 3'-methyl-4-dimethylaminoazobenzene in ratsS Sakamoto, H Hirai, H Taga, et al.
American Journal of Hypertension|October 1, 1994
Comparative effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic-blocking activity, and nitrendipine on lipoprotein and carbohydrate metabolism in patients with hypertensionJ Sasaki, T Ogihara, M Yokoyama, et al.
Veterinary and Comparative Oncology|January 10, 2018
Aberrant expression of microRNAs and the miR-1/MET pathway in canine hepatocellular carcinomaY-C Lai, N Ushio, M M Rahman, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Anticancer Research|March 1, 1991
Inhibition by 1-(2-tetrahydrofuryl)-5-fluorouracil in combination with uracil of hepatocarcinogenesis induced by 3'-methyl-4-dimethylaminoazobenzene in ratsS Sakamoto, H Hirai, H Taga, et al.
American Journal of Hypertension|October 1, 1994
Comparative effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic-blocking activity, and nitrendipine on lipoprotein and carbohydrate metabolism in patients with hypertensionJ Sasaki, T Ogihara, M Yokoyama, et al.
Veterinary and Comparative Oncology|January 10, 2018
Aberrant expression of microRNAs and the miR-1/MET pathway in canine hepatocellular carcinomaY-C Lai, N Ushio, M M Rahman, et al.
Pageof 5